)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
Mind Medicine (MindMed) (MNMD) investor relations material
Mind Medicine (MindMed) Jefferies London Healthcare Conference 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies London Healthcare Conference 2025 summary18 Nov, 2025
Program highlights and clinical progress
MM120, an orally disintegrating tablet of lysergide, is in phase III trials for generalized anxiety disorder (GAD) and major depressive disorder (MDD), with pivotal readouts expected in 2026.
Phase II results showed rapid, durable reductions in anxiety and depression after a single dose, with effects lasting at least three months.
Phase III studies replicate phase II design, focusing on single-dose efficacy, durability, and retreatment patterns over a year.
Three phase III studies will read out in 2025, with a fourth study launching for MDD.
The program aims to address significant unmet needs in mental health, especially where little innovation has occurred in decades.
Market opportunity and differentiation
MM120 targets tens of millions suffering from anxiety and depression, offering a novel, durable treatment option.
The product is positioned as a high-efficacy, long-lasting alternative to current therapies, with commercial prospects bolstered by recent advances in interventional psychiatry.
Unlike daily medications, MM120 is administered in-clinic, potentially reshaping care paradigms.
The approach moves away from psychedelic-assisted therapy, focusing on streamlined, scalable delivery.
Robust phase II data, including high placebo response, increases confidence in phase III translatability.
Financial position and strategic priorities
$259 million was raised to fund pivotal programs, ensuring cash runway through three phase III readouts and into 2027.
Funds will support NDA preparation, state prioritization, KOL education, and commercial launch readiness.
Additional resources enable rapid initiation of a second MDD study and leverage strong enrollment.
Investor interest was high, reflecting confidence in the program and management.
The company is focused on aggressive timelines for regulatory submission and commercialization.
How will clinic-based treatment drive adoption?
MM120's 'lighter touch' model vs. competitors?
Priorities for $259M beyond clinical trials
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Mind Medicine (MindMed) earnings date
Evercore ISI 8th Annual HealthCONx Conference2 Dec, 2025
Next Mind Medicine (MindMed) earnings date
Evercore ISI 8th Annual HealthCONx Conference2 Dec, 2025
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Mind Medicine (MindMed) Inc is a biopharmaceutical company focused on the development of psychedelic-inspired medicines and therapies for mental health and addiction conditions. The company engages in clinical research and product development targeting various psychiatric and neurological disorders. MindMed operates within the healthcare and biotechnology sectors. The company is headquartered in New York, New York, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage